LOGIN
Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head
August 2019
Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis
Int J Surg. 2019 Jul 10;69:23-31Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
14 randomized controlled trials were included in this meta-analysis which sought to investigate the impact of autologous bone marrow-derived mesenchymal stem cell (MSC) administration alongside core decompression on outcomes in treatment of patients with osteonecrosis of the femoral head. Pooled analyses of pain scores from 6 months to 2 years, function from 1 to 2 years, and incidence of eventual...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.